GRI Bio, Inc. (GRI)

NASDAQ

$1.64

$+0.07

(+4.46%)

Regular Market

GRI Bio, Inc. (GRI) Live Price Chart

Last updated: ⁦2026-10-28 19:17:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

GRI Bio, Inc. (GRI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.64, with a market capitalization of $3.28M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.36 to $64.12. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3.28M
Open	$1.57
Day's High	$2,248,100.40
Day's Low	$1.36
Previous Close	$1.58
Volume	5.42K
Average Volume	337.12K
P/E Ratio	--
52-Week High	$64.12
52-Week Low	$1.36
Dividend Yield	--
Earnings Date	--

GRI Bio, Inc. (GRI) Stock Price Today

GRI Bio, Inc. (GRI) is currently trading at $1.64 as of 2026-10-28 19:14:00, up 3.80% ($0.06) from the previous close of $1.58

During today's regular trading session, GRI has traded between $1.36 and $2,248,100.40, with a trading volume of 5.42K shares. The current price is near the lower end of today's range.

GRI Bio, Inc. (GRI) 7-Day Stock Price Change

Over the past seven days, GRI Bio, Inc. (GRI) moved from $1.45 to $1.64, representing a gain of 13.10% ($0.19).

The stock traded between $1.36 and $1.64 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 51.66 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

GRI 52-Week Price Position

Position in Range: 0.4%

52W Low$1.36

52W High$64.12

GRI is currently trading at $1.64, placing it 0.4% of the way from its 52-week low of $1.36 to its 52-week high of $64.12. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is GRI Bio, Inc. (GRI)?

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

GRI Bio, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	5
Exchange	NASDAQ
Company Website	https://www.gribio.com

How to Buy GRI Bio, Inc. (GRI) Stock on MEXC

Eligible investors can buy real shares of GRI Bio, Inc. (GRI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GRI and Place Your Order

Open the RealStocks trading page and search for GRI. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is GRI Bio, Inc. (GRI) stock price today?

GRI Bio, Inc. (GRI) is currently trading at $ 1.64, up 3.80% ($0.06) from the previous close of $ 1.58. Intraday prices update in real time during regular trading hours.

2.Is GRI stock going up or down today?

As of 2026-10-28 19:14:00, GRI is trading at $ 1.64, up 3.80% ($0.06) from its previous close of $ 1.58. The stock has traded between $ 1.36 and $ 2,248,100.40 during today’s regular session. Past price movements do not guarantee future results.

3.What is GRI pre-market price?

As of 2026-10-28 19:14:00, GRI is trading at $ 1.60 in pre-market trading, up 1.27% ($0.02) from the previous close of $ 1.58. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GRI after-hours price?

As of 2026-10-28 19:14:00, GRI is trading at $ 1.60 in after-hours trading, up 1.39% ($0.02) from the regular-session close of $ 1.58. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GRI stock trading now?

GRI trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GRI sit relative to its 52-week high and low?

Over the past 52 weeks, GRI has traded between a low of $ 1.36 and a high of $ 64.12. At $ 1.64, the stock is positioned 0.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is GRI Bio, Inc. in?

GRI Bio, Inc. (GRI) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is GRI Bio, Inc.'s market capitalization and where is it listed?

GRI Bio, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 3.28M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GRI valued in terms of P/E ratio and EPS?

GRI trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4.42. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does GRI Bio, Inc. pay a dividend?

GRI Bio, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.